The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Next generation diabetic therapy and drug delivery systems are used to improve the adherence to insulin in diabetic patients to reduce the risk of complications related to sudden change in the blood sugar level.
The global Next Generation Diabetes Therapy and Drug Delivery market was valued at US$ 1757.8 million in 2023 and is anticipated to reach US$ 7852.9 million by 2030, witnessing a CAGR of 23.3% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Next Generation Diabetes Therapy and Drug Delivery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Next Generation Diabetes Therapy and Drug Delivery.
Report Scope
The Next Generation Diabetes Therapy and Drug Delivery market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Next Generation Diabetes Therapy and Drug Delivery market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Next Generation Diabetes Therapy and Drug Delivery companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
- Johnson & Johnson
- Abbott Laboratories
- Medtronic
- Sanofi
- Novo Nordisk
- MannKind Corporation
- Enteris BioPharma
- Dexcom
- Senseonics
- Medtech
- Synertech
- Zosano Pharma
- Relmada Therapeutics
- Eli Lilly and Company
- Transdermal Specialties
Segment by Type
- Inhalable Insulin
- Oral Insulin
- Insulin Patches
- CGM Systems
- Artificial Pancreas
Segment by Application
- Diagnostic/Clinics
- ICUs
- Home Healthcare
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Next Generation Diabetes Therapy and Drug Delivery companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Inhalable Insulin
1.2.3 Oral Insulin
1.2.4 Insulin Patches
1.2.5 CGM Systems
1.2.6 Artificial Pancreas
1.3 Market by Application
1.3.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostic/Clinics
1.3.3 ICUs
1.3.4 Home Healthcare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Perspective (2019-2030)
2.2 Next Generation Diabetes Therapy and Drug Delivery Growth Trends by Region
2.2.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Region (2019-2024)
2.2.3 Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Region (2025-2030)
2.3 Next Generation Diabetes Therapy and Drug Delivery Market Dynamics
2.3.1 Next Generation Diabetes Therapy and Drug Delivery Industry Trends
2.3.2 Next Generation Diabetes Therapy and Drug Delivery Market Drivers
2.3.3 Next Generation Diabetes Therapy and Drug Delivery Market Challenges
2.3.4 Next Generation Diabetes Therapy and Drug Delivery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue
3.1.1 Global Top Next Generation Diabetes Therapy and Drug Delivery Players by Revenue (2019-2024)
3.1.2 Global Next Generation Diabetes Therapy and Drug Delivery Revenue Market Share by Players (2019-2024)
3.2 Global Next Generation Diabetes Therapy and Drug Delivery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Next Generation Diabetes Therapy and Drug Delivery Revenue
3.4 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio
3.4.1 Global Next Generation Diabetes Therapy and Drug Delivery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Next Generation Diabetes Therapy and Drug Delivery Revenue in 2023
3.5 Next Generation Diabetes Therapy and Drug Delivery Key Players Head office and Area Served
3.6 Key Players Next Generation Diabetes Therapy and Drug Delivery Product Solution and Service
3.7 Date of Enter into Next Generation Diabetes Therapy and Drug Delivery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Type
4.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Type (2019-2024)
4.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Type (2025-2030)
5 Next Generation Diabetes Therapy and Drug Delivery Breakdown Data by Application
5.1 Global Next Generation Diabetes Therapy and Drug Delivery Historic Market Size by Application (2019-2024)
5.2 Global Next Generation Diabetes Therapy and Drug Delivery Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
6.2 North America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
6.4 North America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
7.2 Europe Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
7.4 Europe Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
8.2 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2019-2024)
8.4 Asia-Pacific Next Generation Diabetes Therapy and Drug Delivery Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
9.2 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
9.4 Latin America Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size (2019-2030)
10.2 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2019-2024)
10.4 Middle East & Africa Next Generation Diabetes Therapy and Drug Delivery Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Next Generation Diabetes Therapy and Drug Delivery Introduction
11.1.4 Johnson & Johnson Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Next Generation Diabetes Therapy and Drug Delivery Introduction
11.2.4 Abbott Laboratories Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Next Generation Diabetes Therapy and Drug Delivery Introduction
11.3.4 Medtronic Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.3.5 Medtronic Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Detail
11.4.2 Sanofi Business Overview
11.4.3 Sanofi Next Generation Diabetes Therapy and Drug Delivery Introduction
11.4.4 Sanofi Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.4.5 Sanofi Recent Development
11.5 Novo Nordisk
11.5.1 Novo Nordisk Company Detail
11.5.2 Novo Nordisk Business Overview
11.5.3 Novo Nordisk Next Generation Diabetes Therapy and Drug Delivery Introduction
11.5.4 Novo Nordisk Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.5.5 Novo Nordisk Recent Development
11.6 MannKind Corporation
11.6.1 MannKind Corporation Company Detail
11.6.2 MannKind Corporation Business Overview
11.6.3 MannKind Corporation Next Generation Diabetes Therapy and Drug Delivery Introduction
11.6.4 MannKind Corporation Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.6.5 MannKind Corporation Recent Development
11.7 Enteris BioPharma
11.7.1 Enteris BioPharma Company Detail
11.7.2 Enteris BioPharma Business Overview
11.7.3 Enteris BioPharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.7.4 Enteris BioPharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.7.5 Enteris BioPharma Recent Development
11.8 Dexcom
11.8.1 Dexcom Company Detail
11.8.2 Dexcom Business Overview
11.8.3 Dexcom Next Generation Diabetes Therapy and Drug Delivery Introduction
11.8.4 Dexcom Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.8.5 Dexcom Recent Development
11.9 Senseonics
11.9.1 Senseonics Company Detail
11.9.2 Senseonics Business Overview
11.9.3 Senseonics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.9.4 Senseonics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.9.5 Senseonics Recent Development
11.10 Medtech
11.10.1 Medtech Company Detail
11.10.2 Medtech Business Overview
11.10.3 Medtech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.10.4 Medtech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.10.5 Medtech Recent Development
11.11 Synertech
11.11.1 Synertech Company Detail
11.11.2 Synertech Business Overview
11.11.3 Synertech Next Generation Diabetes Therapy and Drug Delivery Introduction
11.11.4 Synertech Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.11.5 Synertech Recent Development
11.12 Zosano Pharma
11.12.1 Zosano Pharma Company Detail
11.12.2 Zosano Pharma Business Overview
11.12.3 Zosano Pharma Next Generation Diabetes Therapy and Drug Delivery Introduction
11.12.4 Zosano Pharma Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.12.5 Zosano Pharma Recent Development
11.13 Relmada Therapeutics
11.13.1 Relmada Therapeutics Company Detail
11.13.2 Relmada Therapeutics Business Overview
11.13.3 Relmada Therapeutics Next Generation Diabetes Therapy and Drug Delivery Introduction
11.13.4 Relmada Therapeutics Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.13.5 Relmada Therapeutics Recent Development
11.14 Eli Lilly and Company
11.14.1 Eli Lilly and Company Company Detail
11.14.2 Eli Lilly and Company Business Overview
11.14.3 Eli Lilly and Company Next Generation Diabetes Therapy and Drug Delivery Introduction
11.14.4 Eli Lilly and Company Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.14.5 Eli Lilly and Company Recent Development
11.15 Transdermal Specialties
11.15.1 Transdermal Specialties Company Detail
11.15.2 Transdermal Specialties Business Overview
11.15.3 Transdermal Specialties Next Generation Diabetes Therapy and Drug Delivery Introduction
11.15.4 Transdermal Specialties Revenue in Next Generation Diabetes Therapy and Drug Delivery Business (2019-2024)
11.15.5 Transdermal Specialties Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
